Nitta D, Kinugawa K, Imamura T, Iino J, Endo M, Amiya E, Hatano M, Kinoshita O, Nawata K, Ono M, Komuro I
Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.
Department of Internal Medicine 2, The University of Toyama, Toyama, Japan.
Transplant Proc. 2017 Jan-Feb;49(1):125-129. doi: 10.1016/j.transproceed.2016.11.001.
Although many risk factors are reported about graft rejection after heart transplantation (HTx), the effect of HLA mismatch (MM) still remains unknown, especially in the Japanese population. The aim of the present study was to investigate the influence of HLA MM on graft rejection among HTx recipients in Japan.
We retrospectively investigated the association of the number of HLA MM including class I (A, B) and class II (DR) (for each locus MM: 0 to 2, total MM: 0 to 6) and the incidence of moderate to severe acute cellular rejection (ACR) confirmed by endomyocardial biopsy (International Society for Heart and Lung Transplantation grade ≥ 3A/2R) within 1 year after HTx.
Between 2007 and 2014, we had 49 HTx cases in our institute. After excluding those with insufficient data and positive donor-specific antigen, finally 35 patients were enrolled. Moderate to severe ACR was observed in 16 (45.7%) patients. The number of HLA-DR MM was significantly associated with the development of ACR (ACR+: 1.50 ± 0.63, ACR-: 1.11 ± 0.46, P = .029). From univariate analysis, DR MM = 2 was the only independent risk factor for ACR episodes (P = .017). The frequency of ACR within 1 year was significantly higher in those with DR MM = 2 (DR MM = 0 to 1: 0.3 ± 0.47, DR MM = 2: 1.17 ± 1.34 times, P = .007).
The number of HLA-DR MMs was associated with the development and recurrence of ACR episodes among HTx recipients within 1 year after transplantation in Japanese population.
尽管已报道了许多关于心脏移植(HTx)后移植物排斥的危险因素,但HLA错配(MM)的影响仍不明确,尤其是在日本人群中。本研究的目的是调查HLA MM对日本HTx受者移植物排斥的影响。
我们回顾性研究了HLA MM的数量(包括I类(A、B)和II类(DR))(每个位点MM:0至2,总MM:0至6)与HTx后1年内经心内膜心肌活检确诊的中度至重度急性细胞排斥反应(ACR)(国际心肺移植学会分级≥3A/2R)发生率之间的关联。
2007年至2014年,我们研究所共有49例HTx病例。在排除数据不足和供者特异性抗原阳性的患者后,最终纳入35例患者。16例(45.7%)患者发生了中度至重度ACR。HLA-DR MM的数量与ACR的发生显著相关(ACR阳性:1.50±0.63,ACR阴性:1.11±0.46,P = 0.029)。单因素分析显示,DR MM = 2是ACR发作的唯一独立危险因素(P = 0.017)。DR MM = 2的患者1年内ACR的发生率显著更高(DR MM = 0至1:0.3±0.47,DR MM = 2:1.17±1.34次,P = 0.007)。
在日本人群中,HLA-DR MM的数量与移植后1年内HTx受者ACR发作的发生和复发相关。